Navigation Links
Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress
Date:11/5/2008

study in colon

cancer, with the goal of reporting results in 2009.

Peer-Reviewed Publications and Medical Meeting Presentations

-- Two abstracts were accepted for oral presentation at the San Antonio

Breast Cancer Symposium in December 2008:

-- "Risk of distant recurrence using Oncotype DX in postmenopausal

primary breast cancer patients treated with anastrozole or

tamoxifen: a TransATAC study"

-- "GRB7-dependent pathways are potential therapeutic targets in

triple-negative breast cancer"

-- The American Journal of Surgery published results of a study showing

Oncotype DX changed treatment recommendations in 44 percent of node-

negative, estrogen receptor-positive breast cancer patients.

-- Presented results from two studies supporting the use of Oncotype DX in

assessing HER2 gene expression at the ASCO Breast Cancer Symposium in

September.

-- Independent researchers presented results from a small study of

Japanese women demonstrating that the Oncotype DX Recurrence Score(R)

result may predict response to neoadjuvant endocrine therapy including

tamoxifen and anastrozole at the ASCO Breast Cancer Symposium in

September.

Conference Call Details

To access the live conference call today, November 5, at 4:30 p.m. Eastern Time via phone, please dial (877) 356-8064 from the United States and Canada or (706) 758-4314 internationally. The conference ID is 71000165. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through November 12 and may be accessed by dialing (800) 642-1687 from the United States and Canada or (706) 645-9291 internationally. The replay passcode is 71000165.

To access the live and subsequently archived webcast of the conference call, go to the Invest
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Transgenomic, Inc. Reports Second Quarter 2007 Results
2. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
3. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
4. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
7. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
8. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
9. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
10. BioNanoatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
11. BioNanomatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... 2014 Reflecting the importance of the evolution ... Connie Rankin, the founder and president of Customized ... introduced a fresh new approach to the firm’s branding. ... to influence the success of his or her commercial clients ... one of the first in this market to fully embrace ...
(Date:7/18/2014)... 18, 2014 Global biotechnology company ... offices in Cambridge, MA, announces the launch of ... Software product that leverages the power of Next ... MiSeq sequencing platform. The assay and software have ... of Philadelphia (CHOP) and will include a new ...
(Date:7/18/2014)... 18, 2014  On July 18, 2014, ... Shire,s complementary fit and the benefits of ... of the infographic materials will be available ... In accordance with Rule 30.4 ... this announcement will be available on AbbVie,s ...
(Date:7/18/2014)... -- The Basel Declaration presented the ... consecutive year. The award winner, Vladimir Sergeevich Popov from ... at Zürich University for research with animals according to ... head of the animal research laboratory at the Moscow ... adapting experimental animal research as well as student training ...
Breaking Biology Technology:LEED AP Certified ITRA Global / Customized Real Estate Services Introduces New Approach to Its Branding 2Omixon Launches Holotype HLA for NGS-based HLA Genotyping 2Omixon Launches Holotype HLA for NGS-based HLA Genotyping 3NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 2NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 3NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 4NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 5NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 6NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 7Young Moscovite Researcher Receives this Year's "Basel Declaration Award for Education in Animal Research" 2
... one Delaware man,s vision,comes true, Americans will become ... with breast cancer, and to get started on ... an awareness campaign in his home state this,month., ... Tumor Foundation,and early this month kicked off a ...
... Agreement with U.S. Attorney,s, Office for Eastern District of ... Settles State Cases with ... Cephalon, Inc. (Nasdaq:,CEPH) announced today it has finalized a ... for the Eastern District of,Pennsylvania, the U.S. Department of ...
... Publications --, BRITISH COLUMBIA, Canada, Sept. 29 ... VENTURE: IXS;, http://www.ixsbio.com ), a drug development company ... its Dynamic Cross Linking,(DXL(TM)) technology, announces Jeff Morhet, ... company also announces the featuring of,Mr. Morhet in ...
Cached Biology Technology:Delaware Man Spearheads Brain Tumor Awareness 2Cephalon Concludes All Outstanding Federal and State Government Investigations into the Company's Sales and Promotional Practices 2Cephalon Concludes All Outstanding Federal and State Government Investigations into the Company's Sales and Promotional Practices 3Cephalon Concludes All Outstanding Federal and State Government Investigations into the Company's Sales and Promotional Practices 4InNexus Biotechnology CEO to Present at BioContactQuebec 2008 2
(Date:7/22/2014)... Conn. , July 22, 2014 ... the growing m-commerce market, announces its next generation smart ... 30-minute consumer oriented television show that airs on ... NewsWatch regularly features top technology ... July 31st on the History Channel (6:00-6:30am ET/PT) ...
(Date:7/22/2014)... 22, 2014, Cleveland: A type of immune cell ... such as Alzheimer,s disease and multiple sclerosis (MS), ... injury (TBI) and may slow the progression of ... today in the online journal Nature Communications ... Trapp, PhD, Chair of the Department of Neurosciences ...
(Date:7/22/2014)... much is known about the the genus of planthopper ... a new one was recently discovered in the southern ... of Jaen. A description of it appears in the ... http://www.insectscience.org/14.92/ ). , The new species, Conosimus baenai ... hemipterologist, for his contributions to the taxonomy of Iberian ...
Breaking Biology News(10 mins):NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 2NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 3Cleveland Clinic researchers discover neuroprotective role of immune cell 2
... BOSTON (9-24-09) -- The National Institutes of Health today ... led by Boston University biomedical engineer Bela Suki that ... function, with the goal of understanding the possible roles ... metabolic disorders, aging and cancer. NIH today announced ...
... , , , SAN ... the leader in on-demand identity intelligence, announced today its ... U.S. General Services Administration (GSA) Schedule. Under ... identity scoring technology currently used in the daily operations of ...
... part of an effort to develop effective medical therapies that ... Autosomal Dominant Polycystic Kidney Disease (ADPKD), researchers at the University ... cyst walls develop and maintain a vasculature as they grow ... released by epithelial cells that line the liver cyst wall ...
Cached Biology News:Boston University engineer to use $2.5 million NIH grant to cells' reaction to physical force 2ID Analytics Expands Availability of On-Demand Identity Intelligence Solutions for the Government Market 2ID Analytics Expands Availability of On-Demand Identity Intelligence Solutions for the Government Market 3ID Analytics Expands Availability of On-Demand Identity Intelligence Solutions for the Government Market 4The vasculature emerges as a potential therapeutic target in treating ADPKD liver cysts 2
Recombinant Mouse MMP-9, CF...
Phosphorylcholine hapten is conjugated to BSA protein by use of p-diazonium phenylphosphorylcholine....
Human/Mouse/Rat JNK Pan Specific Affinity Purified PAb...
TAR DNA binding protein...
Biology Products: